Trenbolone hexahydrobenzylcarbonate
Clinical data | |
---|---|
Trade names | Parabolan, Hexabolan |
Other names | Trenbolone cyclohexylmethylcarbonate; Estra-4,9,11-trien-17β-ol-3-one 17β-cyclohexylmethylcarbonate |
Routes of administration | Intramuscular injection |
Drug class | Androgen; Anabolic steroid; Androgen ester; Progestogen |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.041.503 |
Chemical and physical data | |
Formula | C26H34O4 |
Molar mass | 410.554 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
|
Trenbolone hexahydrobenzylcarbonate, or trenbolone cyclohexylmethylcarbonate, sold under the brand names Parabolan and Hexabolan, is a synthetic, injected anabolic–androgenic steroid (AAS) of the nandrolone group and an androgen ester – specifically, the C17β hexahydrobenzylcarbonate (cyclohexylmethylcarbonate) ester of trenbolone – which was marketed in France for medical use in humans but has since been discontinued.[1]
It was introduced in France in 1980 and was voluntarily discontinued by its manufacturer in 1997.[1][2] The drug acts as a long-lasting prodrug of trenbolone when administered via intramuscular injection.[1] It was used clinically at a dosage of one ampoule (76 mg, corresponding to 50 mg trenbolone base) every 10 days.[1]
See also
References
- ^ a b c d William Llewellyn (2011). Anabolics. Molecular Nutrition Llc. pp. 619–. ISBN 978-0-9828280-1-4.
- ^ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia. Elsevier. pp. 3307–. ISBN 978-0-8155-1856-3.
Further reading
- Yarrow JF, McCoy SC, Borst SE (2010). "Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity". Steroids. 75 (6): 377–89. doi:10.1016/j.steroids.2010.01.019. PMID 20138077. S2CID 205253265.
External links
- Trenbolone Hexahydrobenzylcarbonate - William Llewellyn's Anabolic.org Archived 2016-04-07 at the Wayback Machine
- v
- t
- e
(incl. AASTooltip anabolic–androgenic steroid)
ARTooltip Androgen receptor antagonists | |||||
---|---|---|---|---|---|
Steroidogenesis inhibitors |
| ||||
Antigonadotropins |
| ||||
Others |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Androgen receptor modulators
- Estrogens and antiestrogens
- Progestogens and antiprogestogens
- List of androgens/anabolic steroids
This article about a steroid is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e